SCHEMBL6344827

SCHEMBL6344827

Cc1nn(-c2ccccn2)c2nc3cc(F)ccc3c(Cl)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPR P35270 4/20 0.46
P2RX7 Q99572 1/20 0.43
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
MAPT P10636 4/20 0.42
GAA P10253 2/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
PIK3CD O00329 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 3/20 0.38
POLB P06746 1/20 0.37
NR3C1 P04150 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353414 0.91 SPR (0.46) SPRP2RX7KDM4EALDH1A1HPGD
SCHEMBL6342725 0.89 SPR (0.47) SPRKDM4EALDH1A1HPGDMAPT
SCHEMBL6342681 0.88 ALDH1A1 (0.42) SPRP2RX7KDM4EALDH1A1HPGD
SCHEMBL6343061 0.86 ALDH1A1 (0.46) SPRKDM4EALDH1A1HPGDMAPT
SCHEMBL6345276 0.86 KDM4E (0.41) SPRP2RX7KDM4EALDH1A1HPGD
SCHEMBL6344836 0.86 KDM4E (0.41) SPRP2RX7KDM4EALDH1A1HPGD
SCHEMBL6342526 0.85 KDM4E (0.44) SPRP2RX7KDM4EALDH1A1HPGD
SCHEMBL6340244 0.84 SPR (0.47) SPRKDM4EALDH1A1HPGDMAPT
SCHEMBL6343076 0.82 KDM4E (0.41) SPRKDM4EALDH1A1HPGDMAPT
SCHEMBL6345022 0.82 MEN1 (0.48) SPRKDM4EALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 SPR 1579/4885P2RX7 414/4885KDM4E 1741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.